Legend Biotech's GAAP loss for 9M 2021 was $297.875 million, up 21.3% from $245.65 million in the prior year. Revenue increased 45.6% to $50.797 million from $34.893 million a year earlier.
Legend Biotech's GAAP loss for 9M 2021 was $297.875 million, up 21.3% from $245.65 million in the prior year. Revenue increased 45.6% to $50.797 million from $34.893 million a year earlier. 
investors.legendbiotech.com
English (US) 